As demonstrated, BPC 157 counteracts free radical formation and free radical-induced lesions [32, 82,83,84]
It specifically targets visceral fat through GH-axis activation
Medications often carry risks of tolerance, dependence, rebound insomnia, and cognitive dulling, while CBT-I may not be accessible, feasible, or fast-acting for all individuals
The "Healing" Peptides Taking Over Wellness (BPC-157, TB-500, and More) The peptides causing controversy in 2026 are NOT FDA-approved
Our hair growth protocols combine the 4 peptides above, often stacked with microneedling, Minoxidil, Finasteride, or PRP depending on the patient
Where things stand (June 2026) CagriSema Phase 3 results have been reported